142 related articles for article (PubMed ID: 20415841)
1. Alverine citrate, simeticone, and Rome III irritable bowel syndrome.
Ford AC
Aliment Pharmacol Ther; 2010 Apr; 31(7):767-8; author reply 768-9. PubMed ID: 20415841
[No Abstract] [Full Text] [Related]
2. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC
Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095
[TBL] [Abstract][Full Text] [Related]
3. On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.
Ducrotte P; Grimaud JC; Dapoigny M; Personnic S; O'Mahony V; Andro-Delestrain MC
Int J Clin Pract; 2014 Feb; 68(2):245-54. PubMed ID: 24147869
[TBL] [Abstract][Full Text] [Related]
4. Influence of simethicone and alverine on stress-induced alterations of colonic permeability and sensitivity in rats: beneficial effect of their association.
Bueno L; Beaufrand C; Theodorou V; Andro-Delestrain MC
J Pharm Pharmacol; 2013 Apr; 65(4):567-73. PubMed ID: 23488786
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
[TBL] [Abstract][Full Text] [Related]
7. Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis.
Martínez-Vázquez MA; Vázquez-Elizondo G; González-González JA; Gutiérrez-Udave R; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2012; 77(2):82-90. PubMed ID: 22672854
[TBL] [Abstract][Full Text] [Related]
8. [Time and again digestion problems. What really helps in irritable bowel syndrome?].
MMW Fortschr Med; 2005 Feb; 147(8):16. PubMed ID: 18441559
[No Abstract] [Full Text] [Related]
9. [Dynamics of clinical symptoms and indices of visceral sensitivity in patients with the irritated bowels syndrome treated with meteospasmyl].
Makarchuk PA; Golovenko OV; Mikhaĭlova TL; Podmarenkova LF
Eksp Klin Gastroenterol; 2005; (1):25-9. PubMed ID: 15991849
[No Abstract] [Full Text] [Related]
10. [A case report of alverine-citrate-induced acute hepatitis].
Han JY; Lee JW; Kim JM; Joo K; Chon U; Lee JI; Jeong S; Lee DH; Kim YS; Min KS
Korean J Hepatol; 2010 Mar; 16(1):75-8. PubMed ID: 20375645
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
12. Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes?
Camilleri M; Mayer EA
Gastroenterology; 2009 Sep; 137(3):766-9. PubMed ID: 19643191
[No Abstract] [Full Text] [Related]
13. Role of antispasmodics in the treatment of irritable bowel syndrome.
Annaházi A; Róka R; Rosztóczy A; Wittmann T
World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Ford AC; Talley NJ; Quigley EM; Moayyedi P
Dis Colon Rectum; 2009 Oct; 52(10):1805; author reply 1806. PubMed ID: 19966623
[No Abstract] [Full Text] [Related]
15. [Complex therapy of patients with the irritable bowel syndrome].
Osipenko MF; Bikbulatova EA; Frolova NN; Loseva NV
Eksp Klin Gastroenterol; 2004; (5):39-44. PubMed ID: 15770859
[No Abstract] [Full Text] [Related]
16. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
Cremonini F; Talley NJ
Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
[TBL] [Abstract][Full Text] [Related]
17. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
18. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
[TBL] [Abstract][Full Text] [Related]
20. The power of placebo in pediatric functional gastrointestinal disease.
Benninga MA; Mayer EA
Gastroenterology; 2009 Oct; 137(4):1207-10. PubMed ID: 19717127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
